Monday, September 30, 2024
HomeTagsESMO Abstract

ESMO Abstract

Zymeworks Announces Release of ESMO Abstract for Phase 1 Study of Zanidatamab

Zymeworks Inc., a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, announced the release of an abstract by ESMO with preliminary results from the company’s Phase...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics